{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigvj5kpe7mcc5wk7cv4hp4s24xq4nsfaf4bqrb3uhzy5nl2nc6rxm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mmfvj7ak4pi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiglkamxczubkrhszmflhwf3vmko36tdiyb45w6pnilu4b5sdugb2q"
    },
    "mimeType": "image/jpeg",
    "size": 26273
  },
  "path": "/2026/05/21/biotech-news-immunovant-shares-surge-on-arthritis-trial-data/?utm_campaign=rss",
  "publishedAt": "2026-05-21T16:27:38.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Trial results for Lilly's \"triple-G\" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout",
  "title": "STAT+: Immunovant shares surge on arthritis trial data",
  "updatedAt": "2026-05-21T16:27:43.000Z"
}